Should patients have the right to join a pragmatic clinical trial for a promising treatment through their physician?
If a promising treatment would otherwise be unavailable, should a patient have the right to pay the costs of receiving it through a pragmatic clinical trial?
How survey respondents would divide funding between the two.
Median response: 79.5% to clinical trials.